- Home
- AMC vs OCUL Comparison
AMC vs OCUL Comparison
Compare AMC & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMC
- OCUL
- Stock Information
- Founded
- AMC 1920
- OCUL 2006
- Country
- AMC United States
- OCUL United States
- Employees
- AMC N/A
- OCUL N/A
- Industry
- AMC Movies/Entertainment
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- AMC Consumer Discretionary
- OCUL Health Care
- Exchange
- AMC Nasdaq
- OCUL Nasdaq
- Market Cap
- AMC 1.6B
- OCUL 1.4B
- IPO Year
- AMC 2013
- OCUL 2014
- Fundamental
- Price
- AMC $4.48
- OCUL $9.16
- Analyst Decision
- AMC Sell
- OCUL Strong Buy
- Analyst Count
- AMC 5
- OCUL 8
- Target Price
- AMC $4.30
- OCUL $16.50
- AVG Volume (30 Days)
- AMC 10.6M
- OCUL 889.3K
- Earning Date
- AMC 11-06-2024
- OCUL 11-14-2024
- Dividend Yield
- AMC N/A
- OCUL N/A
- EPS Growth
- AMC N/A
- OCUL N/A
- EPS
- AMC N/A
- OCUL N/A
- Revenue
- AMC $4,435,200,000.00
- OCUL $61,442,000.00
- Revenue This Year
- AMC N/A
- OCUL $15.49
- Revenue Next Year
- AMC $10.40
- OCUL $13.31
- P/E Ratio
- AMC N/A
- OCUL N/A
- Revenue Growth
- AMC N/A
- OCUL 6.45
- 52 Week Low
- AMC $2.38
- OCUL $2.05
- 52 Week High
- AMC $11.88
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- AMC 51.58
- OCUL 34.86
- Support Level
- AMC $4.17
- OCUL $10.46
- Resistance Level
- AMC $4.87
- OCUL $11.12
- Average True Range (ATR)
- AMC 0.24
- OCUL 0.57
- MACD
- AMC 0.02
- OCUL -0.22
- Stochastic Oscillator
- AMC 44.29
- OCUL 0.60
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, premium presentation. The Company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.